RIFINs displayed on malaria-infected erythrocytes bind KIR2DL1 and KIR2DS1.
Sakoguchi A. et al, (2025), Nature
Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency.
Leithner A. et al, (2025), Proc Natl Acad Sci U S A, 122
Selective requirement of glycosphingolipid synthesis for natural killer and cytotoxic T cells.
Morrison TA. et al, (2025), Cell
Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity.
Kondo T. et al, (2025), Cell
Activation-induced thrombospondin-4 works with thrombospondin-1 to build cytotoxic supramolecular attack particles.
Cassioli C. et al, (2025), Proc Natl Acad Sci U S A, 122
T Cell Resistance: On the Mechanisms of T Cell Non-activation.
Beckers D. et al, (2024), Immune Netw, 24
Microbial mimics supersize the pathogenic self-response.
Capera J. and Dustin ML., (2024), J Clin Invest, 134
Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat.
Zhu Y. et al, (2024), Nature
Quantifying biomolecular organisation in membranes with brightness-transit statistics.
Schneider F. et al, (2024), Nat Commun, 15
Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells.
Sacristán C. et al, (2024), Cell Rep, 43
Soft Synthetic Cells with Mobile Membrane Ligands for Ex Vivo Expansion of Therapy-Relevant T Cell Phenotypes.
Burgstaller A. et al, (2024), Small
A general algorithm for consensus 3D cell segmentation from 2D segmented stacks.
Zhou FY. et al, (2024)
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.
Hamid MHBA. et al, (2024), Nat Immunol, 25, 834 - 846
Regulation of temporal cytokine production by co-stimulation receptors in TCR-T cells is lost in CAR-T cells
PATEL A. et al, (2024), Immunotherapy Advances
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.
Barnkob MB. et al, (2024), Nat Commun, 15
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.
Barnkob MB. et al, (2024), Nat Commun, 15
Transmembrane domain-driven PD-1 dimers mediate T cell inhibition.
Philips EA. et al, (2024), Sci Immunol, 9